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Brain imaging in Klinefelter syndrome (47, XXY) (KS), a genetic disorder characterized by the presence of an
extra X chromosome, may contribute to understanding the relationship between gene expression, brain struc-
ture, and subsequent cognitive disabilities and psychiatric disorders.
We conducted the largest to date voxel-basedmorphometry study of 65 KS subjects and 65 controlsmatched for
age and education and correlated these data to neuropsychological test scores. The KS patients had signiﬁcantly
smaller total brain volume (TBV), total gray matter volume (GMV) and total white matter volume (WMV) com-
pared to controls, whereas no volumetric difference in cerebral spinal ﬂuid (CSF) was found. There were no dif-
ferences in TBV, GMV, WMV or CSF between testosterone treated KS (T-KS) and untreated KS (U-KS) patients.
Compared to controls, KS patients had signiﬁcantly decreased GMV bilaterally in insula, putamen, caudate, hip-
pocampus, amygdala, temporal pole and frontal inferior orbita. Additionally, the right parahippocampal region
and cerebellar volumes were reduced in KS patients. KS patients had signiﬁcantly larger volumes in right
postcentral gyrus, precuneus and parietal regions. Multivariate classiﬁcation analysis discriminated KS patients
from controls with 96.9% (p b 0.001) accuracy. Regression analyses, however, revealed no signiﬁcant association
between GMV differences and cognitive and psychological factors within the KS patients and controls or the
groups combined. These results show that although gene dosage effect of having and extra X-chromosome
may lead to large scale alterations of brain morphometry and extended cognitive disabilities no simple corre-
spondence links these measures.
© 2013 The Authors. Published by Elsevier Inc. All rights reserved.
1. Introduction
Klinefelter syndrome (KS) (47, XXY) affects 1 out of 660 men, mak-
ing it themost common sex-chromosome aneuploidy inmales (Bojesen
et al., 2003). KS is associated with verbal learning disabilities (Ratcliffe,
1999), impairments in memory (Fales et al., 2003) and executive func-
tions (Kompus et al., 2011) and the general intelligence has been found
to range between sub-average and average levels (Barker and Black,
1976; Bender et al., 1999; Fales et al., 2003; Geschwind et al., 1998;
Giedd et al., 2007; Graham et al., 1988; Itti et al., 2006; Kompus et al.,
2011; Lee et al., 2011; Nielsen and Pelsen, 1987; Stemkens et al., 2006;
Tartaglia et al., 2012; van Rijn et al., 2006, 2008). A vulnerability is
also present in KS towards psychiatric diseases such as depression, anx-
iety, schizophrenia, attention deﬁcit hyperactivity disorder and autism
spectrum diseases (Bruining et al., 2009). Themost prominent hormon-
al abnormality in KS is hypergonadotropic hypogonadism. Brain imag-
ing studies of KS may contribute not only to the understanding of the
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neurobiology underlying the cognitive disabilities and the increased risk
of psychiatric diseases that have not been delineated yet in KS (Bryant
et al., 2011), but also to an understanding of X-chromosome linked
mechanisms underlying cognitive disabilities and psychiatric diseases
in general.
Studies using brain imaging techniques in boys and adults with KS
have found signiﬁcant volume differences in multiple brain regions,
but the results are rather discordant. Total brain volume (TBV) was re-
ported by some studies to be reduced (DeLisi et al., 2005; Giedd et al.,
2007; Shen et al., 2004;Warwick et al., 1999)while others report no dif-
ference (Bryant et al., 2011; Patwardhan et al., 2000). Regarding brain
ventricles, these have been reported to be enlarged in some studies
(Giedd et al., 2007; Itti et al., 2006; Shen et al., 2004; Warwick et al.,
1999) while others have found no volumetric differences (DeLisi et al.,
2005; Patwardhan et al., 2000). Furthermore, discrepant data also
exist regarding lobar volumes including the temporal lobes (Bryant
et al., 2011; DeLisi et al., 2005; Giedd et al., 2007; Itti et al., 2006;
Patwardhan et al., 2000; Shen et al., 2004;Warwick et al., 1999), frontal
lobes (Bryant et al., 2011; DeLisi et al., 2005; Giedd et al., 2007; Itti et al.,
2006; Warwick et al., 1999) and parietal lobes (Giedd et al., 2007; Itti
et al., 2006; Shen et al., 2004; Warwick et al., 1999) and the volumes
of more speciﬁc brain structures such as amygdala and hippocampus
(Bryant et al., 2011; DeLisi et al., 2005; Itti et al., 2006; Patwardhan
et al., 2000; Rose et al., 2004; Shen et al., 2004; Warwick et al., 1999)
and the caudate nuclei (Bryant et al., 2011; Giedd et al., 2007;
Warwick et al., 1999) with some studies reporting smaller volumes
for these structures while other studies report these to be of normal
size. All studies that have been published so far had small sample
sizes. Moreover, investigators used different volumetric neuroimaging
techniques and there was considerable variability in studied sample
age as well as the frequency of testosterone treatment (Steinman
et al., 2009).
As KS is associated with hypergonadotropic hypogonadism, many of
the KS patients start testosterone therapy around puberty or later in life
when the syndrome is diagnosed, often with a substantial delay and a
resulting long period of exposure to hypogonadism. Sex hormones and
especially testosterone may have both an ‘organizational effect’ and an
‘activational effect’ on neural pathways (Cooke et al., 1998; Phoenix
et al., 2013), which have raised the question whether testosterone thera-
py in KS patients could have a modulating effect on brain volume. In one
study (Patwardhan et al., 2000) KS patients not receiving testosterone
were found to have smaller temporal volumes than controls, while KS pa-
tients receiving testosterone treatment did not. Other investigators (Itti
et al., 2006) found no signiﬁcant effect of testosterone treatment on
brain volumes. Another area of uncertainty is the possible correlation be-
tween the neuropsychological proﬁle in KS and results of structural brain
imaging. The few studies that attempted to investigate this either had
very small sample sizes (DeLisi et al., 2005; Itti et al., 2006; Patwardhan
et al., 2000;Warwick et al., 1999) and/or involved very fewneuropsycho-
logical tests (Bryant et al., 2011; Patwardhan et al., 2000; Warwick et al.,
1999).
In the present study,we studied brain volumes in a large sample of 65
KS patients using voxel-based morphometry (VBM), and correlated
these data to scores on a comprehensive neuropsychological test battery.
The presented data do not support a correlation betweenmorphometric
indices and neuropsychological parameters or testosterone treatment.
2. Materials and methods
2.1. Participants
Seventy-nine patients with veriﬁed KS recruited from endocrinolo-
gy, genetics and fertility clinics in Denmark agreed to participate in
the study. Seventy-seven of seventy-nine KS patients were registered
by the Danish Cytogenetic Central Register in Denmark and the karyo-
type was conﬁrmed by the register. Two of the KS patients were not
registered in register and were karyotyped using standard techniques
to verify their KS diagnose. Inclusion criteria were ages between 18
and 60 years and signed informed consent. Exclusion criteria were i) a
history of neurological disease or head injury more severe than simple
concussion, ii) current substance abuse, iii) color blindness or iiii)
metal implants not suitable for magnetic resonance (MR) imaging. Sub-
sequently, 14 of the KS patients were excluded from the study due to ei-
ther anatomical scans with motion artifacts (n = 1), missing scan
images (n = 1), developing claustrophobia inside the scanner
(n = 3), too large body-proportion to enter the scanner (n = 2), un-
known metal splinter in ﬁnger (n = 1), chronic solvent-induced en-
cephalopathy diagnosis (n = 1) and use of cannabis within the last
month before examination (n = 5), thus resulting in 65 patients with
KS eligible for the study (mean age 36.8 ± 10.5 (SD) years). Sixty two
(95%) of the KS patients had 47,XXY karyotype and 3 (5%) had chromo-
somal mosaicism (1 patient had 88% 47,XXY/10% 46,XY/2% 48,XXXY; 1
patient with 90% 47,XXY/10% 46,XXY; 1 patient with 40–60% 47,XXY/
40–60% 46, XY). At the time of participation, 44 (68%) of the KS patients
received testosterone treatment (intramuscular testosterone injections
(n = 38), oral testosterone (n = 1), cutaneous testosterone gel
(n = 5)). Fourteen of the 21 KS patients (67%) who did not receive tes-
tosterone treatment had never received treatment with testosterone,
while six had received testosterone therapy in the past for an average
time period of 35.3 months (range: 10 month–7 years) and one KS pa-
tients had received testosterone for an unspeciﬁed period when he was
younger. Sixty of the KS patientswere right-handed, 3were left-handed
and 2 were ambidextrous.
Sixty ﬁvemale controlsmatched for age and educationwere recruit-
ed through advertisement in local hospitals, in local newspapers, at local
work services, among volunteer ﬁre ﬁghters, at citizen service ofﬁces
and at local libraries. Karyotyping on the 73 controlswas not performed,
but none of these showed signs of more than one X-chromosome in an-
drogen receptor polymorphism or X-chromosomemicrosatellite analy-
sis. None of the controls received or had received treatment with
testosterone. Fifty-seven of the controls were right-handed and 8
were left-handed. Inclusion and exclusion criteria were the same as
the criteria for KS patients mentioned above.
All participants received oral and written information about the
study before giving their written consent. The study was approved
by the Danish Data Protection Agency and local ethics committee
(Region Midtjylland, Denmark number M-20080238) and registered
at ClinicalTrials.gov (Clinical trial NCT00999310).
2.2. Cognitive assessment
Participants were administered a 3-h battery of standardized cogni-
tive tests designed to assess major cognitive functions. Administration
and scoring of the tests were done by trained research assistants
under supervision of a psychologist and a senior specialist in clinical
neuropsychology. The test battery consisted of the following cognitive
domains and tests:
▪ Processing speed; tests included Trail Making A and B (Reitan, 1958)
and the Coding subtest of the Wechsler Adult Intelligence Scale —
third edition (WAIS-III) (Wechsler, 1997).
▪ Working memory; tests included Digit Span (DS) and Letter–
Number Sequencing (LN) subtests of WAIS-III (Wechsler, 1997).
▪ Visual/spatial construction and performance; tests included the
Copy subtest of the Rey Complex Figure Test and Recognition
Trial (RCFT) (Meyers and Meyers, 1995) and the Block Design
(BD) and the Matrix Reasoning (MR) subtests of WAIS-III
(Wechsler, 1997).
▪ Visual memory and learning; tests included the Immediate Recall
and Delayed Recall subtests of RCFT (Meyers and Meyers, 1995).
▪ Verbal memory and learning; tests included Rey Auditory Verbal
Learning Test (RAVL) (Nielsen et al., 1989).
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▪ Verbal ﬂuency and comprehension; tests included the Similari-
ties (S) and the Vocabulary (V) subtests of WAIS-III (Wechsler,
1997), Sentence Repetition (Spreen and Benton, 1969), and Ver-
bal ﬂuency tests (animals and words by initial letter N, S and F.
Score was sum of all 4 categories) (Lezak et al., 2004).
▪ Response inhibition; test included the Stroop Color and Word
Test (SCWT) (Golden and Freshwater, 2002).
▪ Executive function; test included Tower of London (TOL)
(Culbertson and Zillmer, 2005) and Wisconsin Card Sorting
tests (WCST) (Heaton et al., 1993).
▪ Intelligence; Full scale Intelligence Quotient (FSIQ), Verbal Intelli-
gence Quotient (VIQ) and Performance Intelligence Quotient (PIQ)
were determined by the following regression equation derived
from summary statistics data e.g. mean, standard deviation, correla-
tions of the subtest from the WAIS-III Danish reference material
(Wechsler, 1997): FSIQ = 40.21 + (1.13 × S) + (1.38 × MR) +
(2.10 × V) + (1.35 × BD); VIQ = 50.91 + (2.14 × S) + (2.76 ×
V); PIQ = 49.86 + (2.57 × MR) + (2.47 × BD).
2.3. Psychological questionnaires
A week prior to the study participants received three self-
administered psychological questionnaires to be completed before the
day of participation. These included questions concerning three psycho-
logical domains:
▪ Psychological distress; SCL-8 (mental illness) (Fink et al., 1999; Fink
et al., 2004a; Fink et al., 2004b), SCL-DEP6 (depression) (Christensen
et al., 2005; Christensen et al., 2010) and SCL-ANX4 (anxiety)
(Christensen et al., 2005; Christensen et al., 2010) derived from the
Symptom Checklist (SCL-90) (Bech, 2005; Derogatis et al., 1973)
used to measure psychological distress.
▪ Autism traits; Autism Spectrum Quotient (AQ) (Baron-Cohen et al.,
2001) measuring autistic traits.
▪ Personality; Revised NEO Personality Inventory (NEO PI-R), short
form (Costa and McCrae, 1992). A 60-item measure of the Big Five
personality traits — neuroticism, extraversion, openness to experi-
ence, agreeableness and conscientiousness.
2.4. Magnetic resonance imaging (MRI)
2.4.1. MRI acquisition
A 3-T General Electrics Medical systems (Milwaukee, WI USA) MR
system with a standard headcoil was used to acquire high-resolution
3D GR contiguous T1-weighted anatomical scans, consisting of 256 ×
256 × 134 voxels with a 0.94 × 0.94 × 1.2 mm3 voxel size, obtained
with a TR of 6.552 ms, a 2.824 ms TE and a 14° ﬂip angle.
2.4.2. MRI data pre-processing
Voxel-basedmorphometry (VBM) analysis was performed using Sta-
tistical Parametric Mapping (SPM8) (http://www.ﬁl.ion.ucl.ac.uk/spm/).
T1-weighted scan images were converted from DICOM format to NIfTI
format and these images were manually inspected to rule out large
scale and focal brain abnormalities as well as acquisition artifacts. In ad-
dition, images weremanually co-registered to the anterior commissure–
posterior commissure axis in order to provide optimal conditions for au-
tomated pre-processing and analysis. Images were classiﬁed into gray
matter (GM), white matter (WM) and cerebrospinal ﬂuid (CSF) using
the uniﬁed segmentation tool in SPM8 (Ashburner and Friston, 2005)
with very light bias regularization (0.0001, 60 mm FWHM cutoff) and
an afﬁne transformation to the ICBM space template (European brains).
For analysis of global brain volumes, we considered the preprocessed tis-
sue classiﬁcation probability in each voxel to be an estimate of regional
GM/WM/CSF volume. Global differences in GM, WM, CFS and total
brain volumes between KS patients and controls were analyzed using
two-sample t-tests on the sum of tissue classiﬁcation probabilities across
all voxels for a given structure type. Age effect on global brain volumes
was analyzed by Spearmann correlation within and between groups.
We did not ﬁnd any signiﬁcant effect of age on global brain volumes
(all p-values N0.05). To enable voxel-wise comparisons, GM images
were further normalized to the templates generated fromDiffeomorphic
Anatomical Registration using Exponentiated Lie algebra (DARTEL)
(Ashburner, 2007). A study speciﬁc template was generated using
DARTEL to minimize between scan variations (Klein et al., 2009). The
template was made using the complete set (n = 130) of segmented
GM and WM scans and linear elastic energy regularization together
with all DARTEL default settings. Finally, the segmented and normalized
images were smoothed with a default 8 mm FWHM Gaussian ﬁlter.
2.4.3. Classiﬁcation analysis
Classiﬁcation analysis was based on the same images as those used
in the SPM analysis. Additionally, each subject's image was scaled by
the global brain volume (GM + WM) in order to parallel the scaling
in the univariate SPM analysis. The classiﬁcation analysis was per-
formed as a whole brain analysis, using the same masking as in the
SPM analysis. A binary classiﬁcation task was set up to classify KS pa-
tients vs. controls. For classiﬁcationwe used Fisher's linear discriminant
analysis (FDA) which is a well known method that considers dimen-
sionality reduction and classiﬁcation jointly. FDA seeks to ﬁnd an opti-
mal subspace where the projected class means are separated the most
in terms of variance (Hastie et al., 1995; Hastie et al., 2009). We used
a version of FDA also referred to as regularized/penalized discriminant
analysis (Hastie et al., 2009) in order to control for model over-ﬁtting
and to ensure model uniqueness. On top of the FDA basis we imple-
mented a simple nearestmean classiﬁer to evaluate the prediction accu-
racy. Leave-one-out (LOO) cross validation was used to evaluate the
prediction accuracy: One subject was routinely held out from the train-
ing sample, and the FDA model was trained on the remaining 129 sub-
jects. The trained model was then used to predict the category of the
out-of-sample subject. This was repeated for all subjects. Selection of
the regularization parameter was based only on training subjects in a
nested LOO cross validation loop. To interpret/visualize the FDA model
we use the model weight vector (Kjems et al., 2002). To estimate a sta-
ble representation of the underlying spatial brain pattern we used the
NPAIRS resampling framework (Strother et al., 2002). This resampling
analysis provides a reproducible brainmap (rSPM) that is on an approx-
imate Z-score scale. Finally, the rSPMwas thresholded according to cor-
rection for multiple comparisons by the false discovery rate (FDR)
procedure (Benjamini and Hochberg, 1995). For further details on
model visualization and the NPAIRS resampling analysis see Strother
et al. (2002) and Rasmussen et al. (2012).
2.5. Statistical analysis
Voxel-based statistical analyses were conducted using a general lin-
ear model approach. Correction for global brain volume (GM + WM)
was done using proportional scaling. Initial analyses included age as a
covariate, however no signiﬁcant voxel-wise effect was seen (all p-
values N0.7 FWE corrected) and the age covariate was removed from
the ﬁnal analysis. Analysis of GM was performed using an explicit
mask, including all voxels with a probability above 5% for the given tis-
sue class. Two between-group contrasts were deﬁned for GM: KS N C
and C N KS and tested with two-sample t-test. P b 0.05 was used as sig-
niﬁcance threshold, whole brain corrected for family-wise error and
cluster size N20 voxels. Anatomical regions were located using WFU
(Wake Forest University School of Medicine) Pickatlas referencing the
AAL atlas (Tzourio-Mazoyer et al., 2002).
To test the relationship between regional brain volumes and psycho-
logical and cognitive variables, we ﬁrst applied principal component
analyses (PCA) (Mardia et al., 1979) to the tests in each individual psy-
chological and cognitive domain. This was done to reduce the dimen-
sionality of the psychological and cognitive variables. The PCA analysis
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was performed by STATA (StataCorp, College Station, TX). The ﬁrst com-
ponent extracted from each domain was included as a covariate in the
general linear model in SPM8 (see Supplementary material for details
about the covariates). Multiple regressions were used to assess the vari-
ation in regional brain volume attributable to the three psychological and
ten cognitive domains. P b 0.05 was used as signiﬁcant threshold,
corrected for family-wise error. Spearman's rank correlation coefﬁcient
was used to test the relationship between global brain volumes and
the three psychological and the ten cognitive domains, employing
Bonferroni's adjustment for multiple testing. Between-group differences
in psychological and cognitive test scores and demographic variables
were analyzed in SPSS (SPSS Inc., Chicago, IL, USA) using independent
two-sample t-tests if datamet the criteria for normal distribution; other-
wise data were analyzed with non-parametric Mann Whitney test. Chi-
square tests were used for nominal variables.
3. Results
3.1. Demographic and psychological characteristics
Demographic and psychological characteristics of participants are
presented in Table 1. There was no difference with respect to age and
educational level between KS patients and controls. KS patients report-
ed signiﬁcantly more symptoms of psychological distress. Furthermore,
KS patients had a different personality proﬁle with a signiﬁcantly higher
level of neuroticism, and a signiﬁcantly lower level of extraversion,
agreeableness and conscientiousness. The KS patients also scored signif-
icantly higher on all subscales of the Autism SpectrumQuotient test, ex-
cept the attention to detail subscale.
3.2. Cognitive test results
The cognitive test scores (Table 2) showed that the KS patients had
signiﬁcantly lower full scale IQ, verbal IQ and performance IQ. Further-
more, KS patients had signiﬁcantly slower processing speed, lower
working memory capacity, signiﬁcantly decreased verbal abilities and
poorer response inhibition compared to controls. No differences in visu-
al abilities were found between the two groups, except for the two tests
inﬂuenced by intelligence (WAIS-BD, WAIS-MR). As for executive func-
tions data from the TOL test indicated poorer planning ability among KS
patients (signiﬁcantly higher total move score and a signiﬁcantly lower
correct score), and reduced mental ﬂexibility as measured with the
WCST (KS patients used signiﬁcantlymore cards, completed signiﬁcant-
ly fewer categories with more errors and perseverative responses).
3.3. MRI data
Signiﬁcantly smaller total brain volume (TBV), total graymatter vol-
ume (GMV) and total white matter volume (WMV) were found in KS
patients compared to controls, whereas there was no signiﬁcant differ-
ence in CSF volume (Table 3). Asymmetries in left and right GM volume
were similar between the two groups (GMV_difKS = −11.2 ± 4.2 mL;
GMV_difc = −11.6 ± 4.1; p = 0.625). There were no signiﬁcant dif-
ferences in TBV, GMV, WMV or CSF between testosterone treated KS
(T-KS) and untreated KS (U-KS) patients. VBM-analysis (Table 4,
Fig. 1) showed that KS patients had signiﬁcantly decreasedGMVbilater-
ally in insula, putamen, caudate, hippocampus, amygdala, temporal pole
and frontal inferior orbita compared to controls. Additionally, the right
cerebellum and parahippocampal gyrus was reduced in KS patients.
KS patients had signiﬁcantly larger volumes in regions of thepostcentral
gyrus, inferior and superior parietal lobules and precuneus, bilaterally,
compared to controls (Table 4, Fig. 1). We did not ﬁnd any signiﬁcant
difference in regional GMV between untreated and treated KS patients
(data not shown). The classiﬁcation analysis correctly discriminated
KS patients from controls with 96.9% accuracy (p b 0.001 using
nonparametric permutation) (four controls were misclassiﬁed). Fig. 2
shows the reproducible brain map (rSPM) extracted within the
NPAIRS resampling framework. The rSPM represents a stable pattern
of brain locations supporting discriminative information to the classiﬁ-
er. The rSPM was thresholded according to p b 0.05 FDR correction for
multiple testing. Hot and cold colors represent positive and negative
Z-scores respectively. The interpretation of the map is as follows: In-
creasing the signal locally in cold areas will make a particular brain
scan more likely to be classiﬁed as a KS patients, these area include
the same brain regions and lobes as found we found by VBM analysis.
Conversely, increasing the signal locally in warm areas will make a
brain scan more likely to be classiﬁed as a control, these areas include
the same brain areas as found by primary VBM analysis.
3.4. Correlation between global and regional brain volume and neuropsy-
chological performance
In the initial across group analyses, we found a signiﬁcant positive
correlation between intelligence and GMV (rho = 0.18, p = 0.04), be-
tween intelligence and WMV (rho = 0.20, p = 0.02) and between vi-
sual performance and WMV (rho = 0.23, p = 0.009) in the 130
subject group. Within controls, we found a positive signiﬁcant correla-
tion between visual performance and GMV (rho = 0.26, p = 0.04)
and between visual performance and WMV (rho = 0.30, p = 0.02),
and a signiﬁcant negative correlation between processing speed and
GMV (rho = −0.30, p = 0.02). No correlations were found within
the group of KS patients. In the subsequent analyses which included
Bonferroni adjustment, we found no signiﬁcant correlation between
psychological and cognitive domains and global GMV, WMV and CSF
in the 130 subject group or within controls separately. Furthermore,
we did not ﬁnd any signiﬁcant correlations between voxel-wise region-
al brain volumes and the 3 psychological and 10 cognitive domains
(Table 5).
4. Discussion
The present study documents signiﬁcantly reduced global and re-
gional brain volumes in KS patients. Based on the brain scans we
could predict a KS diagnosis with 96.9% accuracy. We did not ﬁnd any
signiﬁcant correlation between the reduced brain volumes and neuro-
psychological outcome measures, nor did we demonstrate any signiﬁ-
cant effect of testosterone treatment on brain volumes.
Table 1
Age, education and psychological data. Data are median (total range) or mean ± SD. SCL,
SymptomsCheck List; NEOPI-R, Revised NEOPersonality Inventory; AQ, Autism Spectrum
Quotient.
KS (n = 65) Controls (n = 65) p-Value KS vs. controls
Age (yr) 36.8 ± 10.5 36.8 ± 10.3 0.96
Education (yr) 13 (7–18) 13 (8–18) 0.94
SCL
DEP4 (depression) 3 (0–20) 1 (0–14) 0.01
ANX6 (anxiety) 2 (0–15) 2 (0–8) 0.006
SCL-8 (mental disorder) 6 (0–28) 2.5 (0–19) 0.001
NEO PI-R
Neuroticism 63 (42–78) 50 (31–70) b0.001
Extraversion 44 (22–69) 55 (22–78) b0.001
Openness 51 (28–71) 46 (22–70) 0.23
Agreeableness 51 (22–67) 56 (32–74) 0.002
Conscientiousness 45 (22–71) 51 (22–71) 0.02
AQ
Total 19 (9–41) 14 (7–28) b0.001
Communication skills 3 (0–10) 2 (0–6) 0.01
Social skills 3 (0–10) 1 (0–9) b0.001
Imagination 4 (0–10) 3 (0–8) b0.001
Attention to detail 4 (0–9) 4 (0–8) 0.42
Attention switching 4 (0–10) 3 (0–9) 0.007
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Globally, KS patients had signiﬁcantly smaller TBV, in agreement
with previous studies (Bryant et al., 2011; DeLisi et al., 2005; Giedd
et al., 2007; Shen et al., 2004; Warwick et al., 2003), and signiﬁcantly
smaller GMV andWMV. Other VBM studies of KS patients demonstrate
similar results, i.e., either a signiﬁcantly decreased WMV and GMV in
boys and adolescents (Shen et al., 2004), or a trend towards decreased
WMV (p = 0.059) and GMV (p = 0.07) in boys (Bryant et al., 2011).
However, studies usingROI and LowD techniques found only an isolated
GMVdecrease in boys and adolescents (Giedd et al., 2007) or an isolated
WMV decrease in adults (Rezaie et al., 2009). No volumetric difference
in CSF was found in our study. No study has earlier reported CSF mea-
surements in KS patients. Studies using ROI have found either enlarged
lateral ventricles (Giedd et al., 2007; Shen et al., 2004; Warwick et al.,
2003) or no volumetric differences (DeLisi et al., 2005; Patwardhan
et al., 2000). As we found no volumetric difference in CSF, a putatively
larger lateral ventricle would require smaller CFS volumes in other
brain regions which seems unlikely. In accordance with Rezaie et al.
(2009) we found no difference in left and right hemisphere global
GMV and WMV between KS patients and controls.
The concordance between our ﬁndings of changes in TBV, GMV and
WMV in our adult group of KS patients and other VBM studies of boys
and adolescents with KS, indicates that these differences in brain vol-
umes probably develop during fetal life or early childhood, either due
to the gene dosage of having an extra X-chromosome or to differences
in endogenous testosterone level. Testosterone inﬂuences brain devel-
opment in the human fetus (Knickmeyer and Baron-Cohen, 2006). If –
and to what degree – prenatal and postnatal testosterone levels are af-
fected in KS is uncertain. KS is associated with an increased prevalence
ofmicrophallus and cryptorchidism (Ross et al., 2005) indicating low in-
trauterine testosterone levels. However, studies in KS neonates report
either decreased or normal/high testosterone levels (Aksglaede et al.,
Table 2
Neurocognitive ability in patients with Klinefelter syndrome and controls. IQ, intelligence
quotient; WAIS-III, Wechsler Adult Intelligence Scale — third edition; WAIS-III C, WAIS-III
Coding; TMA, TrailMakingA; TMB, TrailMakingB;WAIS-III DS,WAIS-III Digit Span;WAIS-
III LN, WAIS-III Letter-Number Sequencing; RCFT, Rey Complex Figure Test and Recogni-
tion Trail; WAIS-III BD, WAIS-III Block Design; WAIS-III MR, WAIS-III Matrix Reasoning;
RAVL, Rey Auditory Verbal Learning Test; WAIS-III V, WAIS-III Vocabulary; WAIS-III S,
WAIS-III Similarities; SCWT diff, Stroop Color and Word Test Difference Score; TOL,
Tower of London; WCST, Wisconsin Card Sorting Test; Data are medians (total range) or
means ± SD.
KS (n = 65) Controls (n = 65) p-Value KS vs.
controls
Intelligence
Full scale IQ 87.8 ± 12.0 103.7 ± 11.3 b0.001
Verbal IQ 84.7 ± 12.3 100.8 ± 11.7 b0.001
Performance IQ 96.7 ± 13.2 106.2 ± 10.9 b0.001
Processing speed
WAIS-III C 57 (31–91) 71 (39–112) b0.001
TMA (sec.)a 29 (26–80) 23 (12–64) b0.001
TMB (sec.)a 77 (25–205) 62 (32–208) 0.002
Working memory
WAIS-III DS 13 (8–22) 15 (10–24) b0.001
WAIS-III LN 9 (4–18) 11 (7–18) 0.005
Visual performance
RCFT Copy 33 (22–36) 33 (22–36) 0.86
WAIS-III BD 43 (19–66) 55 (12–66) b0.001
WAIS-III MR 18 (5–25) 21 (7–25) b0.001
Visual memory and learning
RCFT immediate recall 22.5 (9.5–33.0) 22.5 (9.0–34.0) 0.49
RCFT delayed recall 21.5 (11.5–33.0) 21.5 (7.5–34.0) 0.84
Verbal memory and learning
RAVLT 1.trail 5 (2–11) 6 (2–12) 0.003
RAVLT total 43 (21–66) 51 (29–70) b0.001
RAVL delayed recall 10 (0–15) 11 (5–15) 0.13
Verbal performance
Verbal ﬂuency 51 (21–94) 67 (35–107) b0.001
WAIS-III S 17.5 (8.0–26.0) 23 (11–31) b0.001
WAIS-III V 24.5 (8.0–49.0) 37 (12–57) b0.001
Sentence span 15 (10–21) 17.5 (13.0–22.0) b0.001
Response inhibition
SCWT diff 1.72 ± 7.48 3.28 ± 8.3 b0.001
Executive function
WCST cards administereda 113 (70–128) 83 (70–128) b0.001
WCST errors (%)a 26 (11–62) 18(11–58) b0.001
WCST persev. responses (%)a 15 (5–40) 9 (5–34) b0.001
WCST categories completed 6 (1–6) 6 (1–6) 0.007
WCST failure to maintain seta 1 (0–4) 0 (0–5) 0.01
TOL total move scorea 26 (0–67) 16 (0–55) 0.003
TOL total correct score 5 (0–10) 6 (1–10) 0.005
a Lower score means better performance.
Table 3
Brain volumetric measures in KS patients and controls. Data are mean ± SD (p b 0.05, uncorrected). GMV, gray matter volume;WMV, white matter volume; CSF, Cerebrospinal ﬂuid; U-
KS, untreated KS males; T-KS, testosterone treated KS males.
U-KS T-KS KS Controls p-Value t-Value
U-KS vs. T-KS KS vs. controls U-KS vs. T-KS KS vs. controls
n 21 44 65 65 Df = 63 Df = 128
Total gray matter volume (mL) 733.2 ± 47.1 723.9 ± 53.6 726.9 ± 51.4 756.9 ± 59.5 0.50 b0.01 0.68 3.08
Total white matter volume (mL) 532.5 ± 39.1 520.3 ± 40.5 524.3 ± 40.2 548.2 ± 52.3 0.26 b0.01 1.15 2.93
Cerebrospinal ﬂuid (mL) 331.5 ± 29.5 338.8 ± 36.7 336.4 ± 34.5 340.7 ± 34,3 0.43 0.48 −0.78 0.71
Table 4
Peak voxels in regions of gray matter with signiﬁcant volumetric differences between KS
patients and Controls (p b 0.05, FWE). L, left; R, right; MNI, Montreal Neurological Insti-
tute. Z-value, Inf, inﬁnite.
Putative region Hemisphere Cluster
size (voxel)
MNI peak
coordinates
(X,Y,Z)
Z-value
(peak voxel)
KS b controls
Insula L 3133 −38,17,−5 Inf
Caudate −15,18,−8 Inf
Putamen −26,8,−9 Inf
Frontal Inf Orb −21,12,−27 5.66
Insula R 3503 38,14,−5 Inf
Putamen 21.18,−6 7.38
Hippocampus 24,−9,−18 6.85
Parahippocampal
extending
into amygdala
22,−4,−27 6.81
Temporal Pole Sup 27,8,−27 6.67
Frontal Inf Orb 34,23,−11 6.11
Hippocampus extending
into amygdala
L 969 −20,−6,−20 Inf
Temporal Pole Sup L 67 −40,6,−24 6.66
Caudate R 64 21,−10,24 6.36
Cerebellum R 29 28,−57,−32 5.64
KS N controls
Postcentral R 185 21,−40,73 6.95
Precuneus 8,−46,58 6.12
Parietal superior R 79 26,−49,60 5.97
Precuneus L 70 −16,−45,4 5.65
Postcentral L 53 −21,−43,69 6.98
Parietal superior −18,−51,69 6.62
Parietal inferior L 51 −28,−45,48 6.92
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2007; Lahlou et al., 2004). A recent study actually does suggest that in-
trauterine testosterone is decreased in KS fetuses (Manning et al.,
2013). The brain size in girls with congenital adrenal hyperplasia ex-
posed to excessive testosterone, prenatally, is not larger than brains in
female controls, indicating that testosterone prenatally does not deter-
mine global brain size in girls (Merke et al., 2003). In addition, we found
no signiﬁcant difference in global brain sizes between testosterone
treated and untreated KS patients in accordance with previous studies
(Itti et al., 2006; Patwardhan et al., 2000), indicating that exogenous tes-
tosterone does not affect global brain volumes in adult KS patients ei-
ther. In conclusion, the observed difference in global brain size seems
to be an inherited trait speciﬁc to KS, but it remains to be determined
whether genetic or endocrine factors or a combination of these factors
are to blame. This is supported by a study of brain volumes in females
with 47,XXX in which reduced brain volume has been demonstrated
(Warwick et al., 1999).
We observed pervasive differences in regional brain volumes in
brain regions involved in cognitive functions. We found a signiﬁcantly
smaller volume of the caudate nucleus and putamen amongKS patients,
also observed by Giedd et al. (2007) but not in other studies (Shen et al.,
2004; Warwick et al., 2003). The caudate nucleus is part of the circuits
involved in learning (Poldrack et al., 2001) and executive functions
(Alexander et al., 1986). Smaller caudate volume has been found to be
associated with ADHD (Castellanos et al., 1994), which is seen with an
increased prevalence in KS (Bruining et al., 2009). In accordance with
others (DeLisi et al., 2005; Giedd et al., 2007; Patwardhan et al., 2000;
Shen et al., 2004), we demonstrated regional volumetric differences in
the temporal and frontal lobes, regions involved in adaptive learning
and social functions (Kringelbach and Rolls, 2004). We also observed
Fig. 1. Coronal slice representation of gray matter differences between KS patients and
controls. T-map displaying signiﬁcant gray matter cluster differences between the KS pa-
tients and controls (p = 0.05, FWE corrected) is overlaid brain template. Signiﬁcant gray
matter clusters were KS b controls is displayed in orange-red colors. Signiﬁcant graymat-
ter clusters were KS N controls is shown in green-blue colors (t (df), df = 128).
Fig. 2. Whole-brain representation of classiﬁcation analysis (reproducible) brain map
(p b 0.05FDR). Increasing the signal locally in cold areas will make a particular brain
scan more likely to be classiﬁed as a KS patient. Increasing the signal locally in warm
areas will make a brain scan more likely to be classiﬁed as a control.
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decreased hippocampal and parahippocampal volumes in KS patients,
which was also reported by Bryant et al. (2011). Hippocampal/
parahippocampal regions are involved in memory processing (Young
et al., 1997) known to be affected in KS (Fales et al., 2003). Decreased
amygdala volume in KS patients as we found, has been reported previ-
ously (Bryant et al., 2011; Patwardhan et al., 2000; Rose et al., 2004;
Shen et al., 2004). Amygdala is part of the limbic system which is in-
volved in social and emotional processing (Wallentin et al., 2011),
which is known to be affected in KS patients (van Rijn et al., 2008).
Furthermore, we found a signiﬁcantly smaller insula in KS patients. Re-
duced volume of the insula has been associated with impaired social
communication (Baron-Cohen and Belmonte, 2005), impairments
which have also been described in KS patients (van Rijn et al., 2008).
The regional volume abnormalities seen in KS have been proposed to
be due to either hypogonadism or gene dosage effect. A recently pub-
lished study found fetal testosterone to inﬂuence gray matter volume in
speciﬁc temporal, parietal and orbitofrontal areas (Lombardo et al.,
2012). We found no volumetric GM abnormalities in these speciﬁc
brain regions in our KS patients, indicating that the regional volumetric
abnormalities seen in KS most likely are due to the gene dosage effect of
the extra X-chromosome and not directly to the effects of low testoster-
one. The hypothesis that an altered X-chromosome dosage can inﬂuence
regional brain volume is supported by a study who found evidence of
dosage-sensitive X-linked locus inﬂuencing the volume of amygdala
(Good et al., 2003).We found an effect in the same region, albeit extend-
ed to the entire medial and frontal temporal lobe. Furthermore, women
with Turner syndrome who have only one X-chromosome, have re-
duced the volume of the parietal lobe and increased the volume of the
temporal lobe (Cutter et al., 2006; Kesler et al., 2004), indicating that
X-chromosome gene dosage may inﬂuence the size of the parietal and
temporal lobes. Contrary to this there is evidence that testosterone has
an organizational effect on brain volumes. A recent voxel-based mor-
phometry study reported that gray matter volume in parahippocampal
gyri and putamen were increased in boys with early excess of androgen
secretion compared to healthy age-matched boys (Mueller et al., 2011).
Our ﬁnding of decreased gray matter volume in the same area in KS pa-
tients, a syndrome associatedwith androgen insufﬁciency, is in line with
these ﬁndings, suggesting an inﬂuence of androgen on brain regions
such as the parahippocampal area and putamen and perhaps a more
general organizational effect on the brain.
We aimed to associate the neuroanatomical phenotype with the
neuropsychological phenotype seen in KS. It has long been the percep-
tion that regional volumetric abnormalities associated with KS underlie
the neuropsychological phenotype seen in KS, although few studies
have investigated this. We did not ﬁnd any correlation between neuro-
psychological test scores and regional brain volumes. This lack of
correlation has also been observed in four out of the ﬁve existing publi-
cations, although these four publications suffer from a limited number
of participants (n = 10–31) and a limited neuropsychological test bat-
tery (Bryant et al., 2011; DeLisi et al., 2005; Patwardhan et al., 2000;
Warwick et al., 2003). The only published study in KS using a thorough
neuropsychological test battery found an inverse correlation between
ventricular volume and processing speed and executive function,
whereas left temporal lobe volume showed a positive correlation with
language scores and processing speed in right-handed subjects (Itti
et al., 2006). These analyses, however, may reﬂect known between-
group effects, as the analysis was done on the KS patients and controls
combined (Steinman et al., 2009). The lack of correlation between
brain volume and neuropsychological test scores found within our
large sample of KS patients indicates that the explanation of the neuro-
psychological deﬁcits in KS may be related to the micro-architecture,
rather than the mesoscopic anatomical brain level investigated using
VBM. Our data indicate that the neuroanatomical etiology of the neuro-
psychological phenotype of KS is much more complicated than just
simply differences in volumetric measurements. This complexity ismir-
rored in well-known gender difference in GMV. Although females on
average have 10% smaller GMV, it is very difﬁcult to point to any signif-
icant neuropsychological effects of this (Wallentin, 2009). To under-
stand the neuroanatomical etiologies of the neuropsychological
phenotype, we need to investigate the brain by functional scans and in-
vestigate the interaction between behavior, brain function and the pos-
sible relation to X-linked genes and changes in gene expression.
4.1. Strength
This study is the largest study conducted investigating brain vol-
umes in KS participants. Our KS patients and controls were carefully
matched on age and educational background.Weused a comprehensive
neuropsychological test battery. Compared to the ROI, the VBM-method
is an objective method not biased by subjectivity. Furthermore, the
VBM-method allows investigation of the entire brain, not just of easily
quantiﬁed brain structures.
4.2. Limitations
Our data concerning the effect of testosterone on global brain vol-
umes areweakened by a lack of standardization of duration andpharma-
ceutical form of testosterone therapy and the age when initiating
testosterone therapy. The lack of correlation between brain volumes
andneuropsychological test score could be due to the fact that signiﬁcant
changes in neuropsychological test scores are too weak a measurement
to correlate to brain volume in general, or that the neuropsychological
Table 5
Principal component analysis: Domains, tests included and 1.component.WAIS-III,Wechsler Adult Intelligence Scale— third edition; RCFT, Rey Complex Figure Test and Recognition Trial;
RAVLT, Rey Auditory Verbal Learning Test; SCWT, Stroop Color and Word Test; WCST, Winconsin Card Sorting Test; TOL, Tower of London Test.
Domain Test Variability accounted for by
1.component (%)
Psychological domain
Psychological distress (3 subtests) SCL-DEP4, SCL-ANX 6, SCL-8 87.5
Personality (5 subscales from NEO PI-R) Neuroticism, extraversion, openness, agreeableness, conscientiousness 42.2
Autism traits (5 subscales from AQ) Communication, social skills, imagination, attention to detail, attention switching 42.4
Cognitive domain
Intelligence (3 subscales) Full scale IQ, verbal IQ, performance IQ 80.9
Processing speed (3 subtests) WAIS-III C, TMA, TMB 73.9
Working memory (2 subtests) WAIS-III DS, WAIS-III LN 78.7
Visual performance (3 subtests) WAIS-III MR, WAIS-III BD, RCFT copy 60.4
Visual learning and memory (2 subtests) RCFT immediate recall, RCFT delayed recall 95.8
Verbal learning and memory (3 subscales) RAVL 1.trail, RAVL total, RAVL delayed recall 78.2
Verbal performance (4 subtests) Fluency, sentence span, WAIS-III S, WAIS-III V 71.4
Response inhibition (1 subtest) SCWT diff –
Executive function: planning (2 subscales) TOL total move score, TOL total correct score 93.0
Executive function: ﬂexibility (5 subscales) WCST cards administered, WCST error(%), WCST persev.
responses %, WCST categories completed, WCST failure to maintain set
74.2
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test score are inﬂuenced by other parameters (such as depression) blur-
ring the test score.
5. Conclusion
In summary, we present global and regional brain volumetric mea-
surements and their possible associations to the neuropsychological phe-
notype and testosterone therapy in the largest cohort of KS patients to
date. Our data suggest that KS is associated with global and regional
brain volumetric changes, and that these changes probably are due to a
gene dosage effect rather than hypogonadism. We did not ﬁnd evidence
that testosterone therapy affects brain volume inKS or that the neuropsy-
chological phenotype can be explained by differences in brain volume.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2013.10.013.
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